Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 4.65
(1.09%)
CNY 4.65
(1.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 118.37 Million CNY | -45.37% |
| 2022 | 216.66 Million CNY | -41.49% |
| 2021 | 370.3 Million CNY | 48.17% |
| 2020 | 249.92 Million CNY | -5.39% |
| 2019 | 264.17 Million CNY | -9.47% |
| 2018 | 291.8 Million CNY | -11.23% |
| 2017 | 328.73 Million CNY | 0.8% |
| 2016 | 326.13 Million CNY | -18.21% |
| 2015 | 398.76 Million CNY | -23.82% |
| 2014 | 523.47 Million CNY | 33.25% |
| 2013 | 392.86 Million CNY | 6.42% |
| 2012 | 369.16 Million CNY | 154.8% |
| 2011 | 144.88 Million CNY | 46.36% |
| 2010 | 98.99 Million CNY | 107.62% |
| 2009 | 47.68 Million CNY | 58.91% |
| 2008 | 30 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 96.63 Million CNY | 13.43% |
| 2024 Q1 | 102.92 Million CNY | -13.05% |
| 2024 Q2 | 85.19 Million CNY | -17.23% |
| 2023 Q2 | 136.91 Million CNY | -9.12% |
| 2023 Q3 | 137.43 Million CNY | 0.38% |
| 2023 Q4 | 118.37 Million CNY | -13.87% |
| 2023 Q1 | 150.66 Million CNY | -30.46% |
| 2023 FY | 118.37 Million CNY | -45.37% |
| 2022 Q3 | 322.49 Million CNY | 1.85% |
| 2022 Q1 | 342.32 Million CNY | -7.55% |
| 2022 FY | 216.66 Million CNY | -41.49% |
| 2022 Q4 | 216.66 Million CNY | -32.82% |
| 2022 Q2 | 316.62 Million CNY | -7.51% |
| 2021 Q1 | 213.99 Million CNY | -14.38% |
| 2021 Q4 | 370.3 Million CNY | 78.31% |
| 2021 Q2 | 202.95 Million CNY | -5.16% |
| 2021 Q3 | 207.67 Million CNY | 2.32% |
| 2021 FY | 370.3 Million CNY | 48.17% |
| 2020 Q2 | 259.93 Million CNY | -1.85% |
| 2020 FY | 249.92 Million CNY | -5.39% |
| 2020 Q4 | 249.92 Million CNY | -10.33% |
| 2020 Q1 | 264.82 Million CNY | 0.25% |
| 2020 Q3 | 278.7 Million CNY | 7.22% |
| 2019 Q3 | 220.67 Million CNY | -9.64% |
| 2019 Q2 | 244.23 Million CNY | -0.9% |
| 2019 Q1 | 246.44 Million CNY | -15.54% |
| 2019 FY | 264.17 Million CNY | -9.47% |
| 2019 Q4 | 264.17 Million CNY | 19.71% |
| 2018 Q2 | 282.88 Million CNY | 4.44% |
| 2018 FY | 291.8 Million CNY | -11.23% |
| 2018 Q4 | 291.8 Million CNY | 7.0% |
| 2018 Q3 | 272.71 Million CNY | -3.6% |
| 2018 Q1 | 270.86 Million CNY | -17.6% |
| 2017 Q2 | 300.82 Million CNY | -3.31% |
| 2017 Q4 | 328.73 Million CNY | 10.81% |
| 2017 Q3 | 296.67 Million CNY | -1.38% |
| 2017 FY | 328.73 Million CNY | 0.8% |
| 2017 Q1 | 311.12 Million CNY | -4.6% |
| 2016 Q1 | 338.4 Million CNY | -15.14% |
| 2016 Q4 | 326.13 Million CNY | 9.94% |
| 2016 Q3 | 296.65 Million CNY | -6.67% |
| 2016 Q2 | 317.84 Million CNY | -6.07% |
| 2016 FY | 326.13 Million CNY | -18.21% |
| 2015 Q1 | 447.38 Million CNY | -14.54% |
| 2015 Q2 | 453.46 Million CNY | 1.36% |
| 2015 Q3 | 364.3 Million CNY | -19.66% |
| 2015 FY | 398.76 Million CNY | -23.82% |
| 2015 Q4 | 398.76 Million CNY | 9.46% |
| 2014 Q4 | 523.47 Million CNY | 39.12% |
| 2014 Q3 | 376.28 Million CNY | -4.47% |
| 2014 FY | 523.47 Million CNY | 33.25% |
| 2014 Q1 | 377.86 Million CNY | -3.82% |
| 2014 Q2 | 393.91 Million CNY | 4.25% |
| 2013 Q1 | 353.85 Million CNY | -4.15% |
| 2013 Q4 | 392.86 Million CNY | 3.78% |
| 2013 Q3 | 378.55 Million CNY | -0.46% |
| 2013 Q2 | 380.31 Million CNY | 7.48% |
| 2013 FY | 392.86 Million CNY | 6.42% |
| 2012 Q1 | 205.37 Million CNY | 41.75% |
| 2012 Q2 | 198.89 Million CNY | -3.16% |
| 2012 FY | 369.16 Million CNY | 154.8% |
| 2012 Q3 | 262.42 Million CNY | 31.94% |
| 2012 Q4 | 369.16 Million CNY | 40.68% |
| 2011 Q4 | 144.88 Million CNY | 0.0% |
| 2011 Q2 | 99.18 Million CNY | 0.0% |
| 2011 FY | 144.88 Million CNY | 46.36% |
| 2010 FY | 98.99 Million CNY | 107.62% |
| 2009 FY | 47.68 Million CNY | 58.91% |
| 2008 FY | 30 Million CNY | 0.0% |